Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1242
| Despition | MC3 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1750 | Human LCN1 Protein (AC1750) | 5 µg | inquiry |
| ACPP-1526 | Human KCTD11 Protein (AC1526) | 2 µg | inquiry |
| ACPP-1451 | Human ALDOC Protein, His (AC1451) | 5 µg | inquiry |
| ACPP-1614 | Human MPPED2 Protein (AC1614) | 2 µg | inquiry |
| ACPP-1818 | Mouse FGF 9 Protein (AC1818) | 2 µg | inquiry |
| ACPP-1729 | Human OCM Protein (AC1729) | 2 µg | inquiry |
| ACPP-1841 | Human DDAH1 Protein (AC1841) | 5 µg | inquiry |
| ACPP-1194 | Calcium Sensing Receptor Blocking Peptide (AC1194) | 250 µg | inquiry |
| ACPP-1820 | Rat CNTF Protein, His (AC1820) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.